Skip to content
★ Sign in to follow
Nika Pharmaceuticals, Inc logo

Nika Pharmaceuticals, Inc Stock: price and insider trades · United States

US·Mcap US$429.9MHealth Care

No insider purchase over the last 90 days. The latest, by NIKA PHARMACEUTICALS, INC, was filed 19 Mar 2024.

Nika Pharmaceuticals, Inc: what insiders have been doing

Nika Pharmaceuticals, Inc, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The past year has been quiet: not a single insider filing for Nika Pharmaceuticals, Inc. The previous disclosure was published on 19 March 2025.

The full history, which starts in 2024, counts 1 purchase against 7 sales.

For comparison within the same sector, see the insider buying recorded at UCB. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
12
Thresholds
n/a
Buy Volume
€126,524
1 ops. · all time
Sell Volume
€858,932
7 ops. · all time

Who traded when

BuySale
Dimitar Slavchev Savov1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.41
Analyst consensus
·
Income statement
EBITDA-US$76.4k
Net income-US$76.4k0.0% margin
Valuation
Beta-1.71
Balance sheet & cash
Market capUS$429.9M
Total debtUS$24k
Free Cash Flow-US$79.7k
Profitability & ownership
ROA-235.0%
% insiders86.0%
% institutions0.0%
Last declaration on 19 March 2025
Declarations12 total
  • ▼
    CEO, CFO, PresidentExecutives
    500,000 USD30SEC
    2,000,000 shares@ US$0.25100.0% of flowCommon StockSEC:0001826466-25-000024:0
  • ▼
    Related company / holdingExecutives
    56,000 USD30SEC
    3,500,000 shares@ US$0.016100.0% of flowCommonSEC:0001826466-24-000034:8
  • ▲
    Related company / holdingExecutives
    137,868 USD0SEC
    11,489,000 shares@ US$0.012CommonSEC:0001826466-24-000034:1
    Canonical exit: 12 Jul 2022 (T+90)
  • ●
    Related company / holdingExecutives
    0SEC
    333,181,000 shares0CommonSEC:0001826466-24-000034:2
  • ▼
    Related company / holdingExecutives
    140,000 USD0SEC
    7,000,000 shares@ US$0.02CommonSEC:0001826466-24-000034:3
  • ▼
    Related company / holdingExecutives
    25,000 USD0SEC
    1,250,000 shares@ US$0.02CommonSEC:0001826466-24-000034:4
  • ▼
    Related company / holdingExecutives
    111,000 USD0SEC
    3,000,000 shares@ US$0.037CommonSEC:0001826466-24-000034:5
  • ▼
    Related company / holdingExecutives
    63,000 USD0SEC
    6,300,000 shares@ US$0.01CommonSEC:0001826466-24-000034:6
  • ▼
    Related company / holdingExecutives
    15,000 USD0SEC
    1,500,000 shares@ US$0.01CommonSEC:0001826466-24-000034:7
  • ●
    Related company / holdingExecutives
    0SEC
    145,000,000 shares0CommonSEC:0001826466-24-000035:1
  • ●
    Related company / holdingExecutives
    0SEC
    5,000,000 shares@ €47,600.0001CommonSEC:0001826466-24-000035:0
  • ●
    Related company / holdingExecutives
    0SEC
    10,000,000 sharesPreferred A StockSEC:0001826466-24-000034:0

12 of 12 declarations

About Nika Pharmaceuticals, Inc

Nika Pharmaceuticals, Inc is a company focused on the development and commercialization of pharmaceutical products. It is listed on NASDAQ under the ticker XNAS.